Altis Labs raises $25 million for oncology-trial AI
Altis Labs raised a $25 million Series A, CEO Felix Baldauf-Lenschen told Axios Pro. The AI software company analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, supporting a drug-devel...
TrialAtlas improves detection of clinical-trial design flaws in preprint tests
Researchers introduced TrialAtlas, a multi-agent AI system that analyzes literature, competing trials, regulatory precedents and historical drug applications to help plan clinical development. In a preprint evaluation built from 2...
Alibaba releases open medical AI model for reading abdominal CT scans
Alibaba's Damo Academy has open-sourced RADAR, an AI model that the company says can read CT scans and identify about 150 abdominal conditions, including cancers. A study published in Science tested it on nearly 40,000 real-world ...
Virtual cells help researchers distinguish how drugs affect living cells
UC San Diego researchers built two computer models that track how mitochondria, the energy-producing structures inside cells, move and change shape after drug treatment. Both studies used three-dimensional microscopy movies to cap...
Mithrl raises $20 million for biopharma AI infrastructure
Mithrl raised a $20 million Series A led by Obvious Ventures, CEO Vivek Adarsh told Axios. The company integrates its proprietary biomedical world model with pharmaceutical companies' research-and-development systems. The round gi...
OECD survey finds wider use of worker-sanction software in US firms
An OECD survey of 6,047 firms across six countries found 67% of US firms use software to sanction poor performance, versus 4% across France, Germany, Italy and Spain. It found US firms were also more likely to monitor conversation...